These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38143567)

  • 21. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
    Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.
    Motegi SI; Sekiguchi A; Toki S; Kishi C; Endo Y; Yasuda M; Ikeuchi H; Sakairi T; Hara K; Yamaguchi K; Maeno T; Hiromura K; Ishikawa O
    Eur J Dermatol; 2019 Oct; 29(5):511-517. PubMed ID: 31617496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y; Fu Q; Wang R; Guo Q; Bao C
    J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports.
    Takahashi R; Yoshida T; Morimoto K; Kondo Y; Kikuchi J; Saito S; Ishigaki S; Kaneko Y; Takeuchi T; Itoh H; Oya M
    Clin Med Insights Case Rep; 2021; 14():11795476211036322. PubMed ID: 34377045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis.
    Aissaoui H; Alsibai KD; Khayath N
    Clin Pract; 2021 Apr; 11(2):235-240. PubMed ID: 33922105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease：A case report.
    Kagawa H; Tsujino K; Yamamoto Y; Iwai A; Hara R; Matsuki T; Fukushima K; Oshitani Y; Yoshimura K; Miki M; Miki K; Kitada S; Mori M; Kida H
    Respir Med Case Rep; 2020; 29():101016. PubMed ID: 32055439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and HRCT features of amyopathic dermatomyositis associated with interstitial lung disease: A retrospective study of 128 patients with connective tissue disease-related interstitial lung disease.
    Wu T; Zhou H; Xu S; Deng Z; Zhang Y; Ding Q
    Am J Med Sci; 2023 May; 365(5):429-436. PubMed ID: 36521530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of clinically amyopathic dermatomyositis that was refractory to intensive immunosuppressive therapy including tofacitinib, but successfully treated with plasma exchange therapy.
    Hiraoka D; Ishizaki J; Horie K; Matsumoto T; Suemori K; Takenaka K; Hasegawa H
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):194-198. PubMed ID: 34984465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An autopsy case of anti-MDA5 antibody-positive amyopathic dermatomyositis with an initial manifestation of panniculitis on the left upper arm.
    Onose T; Kido T; Okada I; Yamazaki M; Hounoki H; Makino T; Yamauchi N; Matsushita T; Tobe K; Shinoda K
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):86-90. PubMed ID: 37340862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies.
    Hiramatsu T; Murano M; Nakai S; Murakami Y; Nishimoto K; Matsushima S; Harada M; Uto T; Sato J; Imokawa S; Suda T
    Respir Med Case Rep; 2022; 36():101606. PubMed ID: 35242519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interstitial Lung Disease-Complicated Anti-MDA5 Antibody in Clinically Amyopathic Dermatomyositis Patients: Report of Two Cases With Distinct Clinical Features.
    Pacot L; Pouchot J; De Prost N; Senant M; Tartour E; Le Pimpec-Barthes F; Israel-Biet D; Dragon-Durey MA
    Front Med (Lausanne); 2020; 7():77. PubMed ID: 32211415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical characteristics and prognostic factors of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated interstitial lung disease].
    Zou RY; Zhao Q; Tian YQ; Yan X; Qiu XH; Gao YJ; Liu Y; Huang M; Cao M; Dai JH; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Aug; 46(8):781-790. PubMed ID: 37536988
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.
    Xu A; Ye Y; Fu Q; Lian X; Chen S; Guo Q; Lu LJ; Dai M; Lv X; Bao C
    Rheumatology (Oxford); 2021 Jul; 60(7):3343-3351. PubMed ID: 33331866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interstitial lung disease-associated with amyopathic dermatomyositis and anti-MDA5 autoantibodies].
    Gerfaud-Valentin M; Ahmad K; Piegay F; Fabien N; Raphanel B; Cordier JF; Cottin V
    Rev Mal Respir; 2014 Nov; 31(9):849-53. PubMed ID: 25433590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis.
    Kurasawa K; Arai S; Namiki Y; Tanaka A; Takamura Y; Owada T; Arima M; Maezawa R
    Rheumatology (Oxford); 2018 Dec; 57(12):2114-2119. PubMed ID: 30060040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early initiation of plasma exchange therapy for a patient with anti-MDA5 autoantibody-positive dermatomyositis developing rapidly progressive interstitial lung disease.
    Sasaki N; Ishii A; Kurabayashi T; Sugiyama M; Izumi Y; Nakagome Y; Hirano K; Sasaki S; Kondo Y; Nogi S; Nishikawa A; Hosono Y; Yamada C; Sato S
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):87-94. PubMed ID: 33048020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations.
    Aoyama J; Hayashi H; Yajima C; Takoi H; Tanaka T; Kashiwada T; Kokuho N; Terasaki Y; Nishikawa A; Gono T; Kuwana M; Saito Y; Abe S; Seike M; Gemma A
    Respir Med Case Rep; 2019; 26():193-196. PubMed ID: 30723666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
    Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
    BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative CT analysis of interstitial pneumonia in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a single center, retrospective study.
    Yamaguchi K; Nakajima T; Yamaguchi A; Itai M; Onuki Y; Shin Y; Uno S; Muto S; Kouno S; Yatomi M; Aoki-Saito H; Hara K; Endo Y; Motegi SI; Muro Y; Nakasatomi M; Sakairi T; Hiromura K; Katsumata N; Hirasawa H; Tsushima Y; Maeno T
    Clin Rheumatol; 2022 May; 41(5):1473-1481. PubMed ID: 35034225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.